This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCabe, C. D. Articles by Moreno, C. S. Search for Related Content PubMed PubMed Citation Articles by McCabe, C. D. Articles by Moreno, C. S.

Genome-Wide Analysis of the Homeobox C6 Transcriptional Network in Prostate Cancer

¹ Department of Pathology and Laboratory Medicine and ² Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia and ³ Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina

Requests for reprints: Carlos S. Moreno, Department of Pathology and Laboratory Medicine, Winship Cancer Institute, Emory University, Whitehead Research Building, Room 105J, 615 Michael Street, Atlanta, GA 30322. Phone: 404-712-2809; Fax: 404-727-8538; E-mail: cmoreno{at}emory.edu.

Key Words: Prostate Cancer • Homeobox • HOXC6 • transcription • systems biology

Homeobox transcription factors are developmentally regulated genes that play crucial roles in tissue patterning. Homeobox C6 (HOXC6) is overexpressed in prostate cancers and correlated with cancer progression, but the downstream targets of HOXC6 are largely unknown. We have performed genome-wide localization analysis to identify promoters bound by HOXC6 in prostate cancer cells. This analysis identified 468 reproducibly bound promoters whose associated genes are involved in functions such as cell proliferation and apoptosis. We have complemented these data with expression profiling of prostates from mice with homozygous disruption of the Hoxc6 gene to identify 31 direct regulatory target genes of HOXC6. We show that HOXC6 directly regulates expression of bone morphogenic protein 7, fibroblast growth factor receptor 2, insulin-like growth factor binding protein 3, and platelet-derived growth factor receptor (PDGFRA) in prostate cells and indirectly influences the Notch and Wnt signaling pathways in vivo. We further show that inhibition of PDGFRA reduces proliferation of prostate cancer cells, and that overexpression of HOXC6 can overcome the effects of PDGFRA inhibition. HOXC6 regulates genes with both oncogenic and tumor suppressor activities as well as several genes such as CD44 that are important for prostate branching morphogenesis and metastasis to the bone microenvironment. [Cancer Res 2008;68(6):1988–96]

This article has been cited by other articles:

				C. D. Scharer, C. D. McCabe, M. Ali-Seyed, M. F. Berger, M. L. Bulyk, and C. S. Moreno Genome-Wide Promoter Analysis of the SOX4 Transcriptional Network in Prostate Cancer Cells Cancer Res., January 15, 2009; 69(2): 709 - 717. [Abstract] [Full Text] [PDF]